FactSet
FactSet's revenue rose 6.7% to $2.5 billion in fiscal 2026. Its operating margin was 28.3%, down from 32.2% a year earlier. Free cash flow was $707 million, up 14.6%. It paid out $808 million in dividends and buybacks, 114% of free cash flow. The diluted share count fell 4.6%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2017 to 2026, earnings per share grew 9.4% a year and net income 8.4% a year, as buybacks cut the share count by 8%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value FactSet yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from FactSet's 10-K and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from FactSet's fiscal 2026 free cash flow of $707M, net cash of −$1.1B at August 31, 2026 and 37 million diluted shares, from its filings. The scenarios are fitted to FactSet: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 5.9% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 9% for a business of moderate risk (Financial Exchanges & Data); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $323.39
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from FactSet's earnings per share of $14.57 (in fiscal 2026). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 22.2×, the middle of FactSet's own P/E today, its peers' median and its sector's median (FactSet's own P/E today) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 10%, 9% and 8%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $323.39
- Value at this multiple, against the last close
- —
- FactSet's P/E at the last close
- 22.2×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| MSCIMSCI | $617.67 | $18.90 | 32.7× |
| Cboe Global MarketsCBOE | $335.25 | $12.83 | 26.1× |
| CME GroupCME | $308.06 | $12.19 | 25.3× |
| FactSetFDS | $323.39 | $14.57 | 22.2× |
| MorningstarMORN | $225.29 | $10.52 | 21.4× |
Balance sheet
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | 536 | 458 | 493 | 355 | 265 |
| Debt incl. finance leases | 1,982 | 1,613 | 1,366 | 1,368 | 1,370 |
| Net debt (negative means net cash) | 1,446 | 1,155 | 873 | 1,013 | 1,105 |
| Net debt to EBITDA | 2.6x | 1.6x | 1.1x | 1.1x | 1.2x |
| Debt to equity | 1.5x | 1.0x | 0.7x | 0.6x | 0.7x |
| Interest coverage | 13.3x | 9.5x | 10.7x | 13.3x | 12.8x |
| Current ratio | 2.0x | 1.6x | 1.2x | 1.4x | 0.6x |
| Quick ratio | 2.0x | 1.6x | 1.2x | 1.4x | 0.6x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, 1 insider bought $126,465 of FactSet shares on the open market, and 2 insiders sold $1.5 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jan 12, 2026 | Malcolm FrankDirector | Sold | 2,572 | $295.70 | $760,547 | Form 4 |
| Jan 8, 2026 | Laurie SiegelDirector | Sold | 2,572 | $296.25 | $761,944 | Form 4 |
| Nov 6, 2025 | Goran SkokoEVP, Chief Revenue Officer | Bought | 500 | $252.93 | $126,465 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Pass | Pass |
| Current ratio rose | Fail | Pass | Fail |
| Share count didn't rise | Pass | Pass | Pass |
| Gross margin rose | Pass | Fail | Fail |
| Revenue rose relative to assets | Pass | Pass | Pass |
| F-score | 8 of 9 | 8 of 9 | 6 of 9 |
| Accruals ratio | −4.1% | −3.1% | −6.8% |
Compare
Put FactSet side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| FactSet | FY26 | 6.7% | 28.3% | 28.6% | 18.2% | 1.2x | 6 | |
| Morningstar | FY25 | 7.5% | 21.5% | 18.1% | 22.5% | 0.8x | 6 | Compare |
| MSCI | FY25 | 9.8% | 54.7% | 49.4% | 44.5% | 3.3x | 7 | Compare |
| Cboe Global Markets | FY25 | 15.1% | 31.1% | 35.7% | 22.8% | −0.5x | 9 | Compare |
| CME Group | FY25 | 6.4% | 64.9% | 64.3% | 11.8% | −0.3x | 7 | Compare |
10 years of figures
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 1,221 | 1,350 | 1,435 | 1,494 | 1,591 | 1,844 | 2,086 | 2,203 | 2,322 | 2,476 |
| Revenue growth | 8.3% | 10.6% | 6.3% | 4.1% | 6.5% | 15.9% | 13.1% | 5.6% | 5.4% | 6.7% |
| Gross profit | 655 | 691 | 772 | 799 | 805 | 973 | 1,112 | 1,191 | 1,224 | 1,253 |
| Research and development | 215 | 217 | 215 | 224 | 250 | 255 | 267 | 265 | 301 | 346 |
| Operating income | 352 | 366 | 438 | 440 | 474 | 476 | 629 | 701 | 748 | 700 |
| Net income | 258 | 267 | 353 | 373 | 400 | 397 | 468 | 537 | 597 | 534 |
| Diluted EPS (US$) | 6.51 | 6.78 | 9.08 | 9.65 | 10.36 | 10.25 | 12.04 | 13.91 | 15.55 | 14.57 |
| Diluted shares (millions) | 40 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 38 | 37 |
| Cash flow | ||||||||||
| Cash from operations | 320 | 386 | 427 | 506 | 555 | 538 | 646 | 700 | 726 | 822 |
| Capital expenditure | 37 | 34 | 59 | 78 | 61 | 51 | 61 | 86 | 109 | 115 |
| Free cash flow | 284 | 352 | 368 | 428 | 494 | 487 | 585 | 615 | 617 | 707 |
| Dividends paid | 81 | 89 | 100 | 110 | 118 | 126 | 139 | 151 | 160 | 164 |
| Share buybacks | 261 | 304 | 220 | 200 | 265 | 19 | 177 | 235 | 300 | 644 |
| Acquisitions | 303 | 15 | 0 | 0 | 58 | 1,982 | 24 | 0 | 348 | 0 |
| Stock-based compensation | 34 | 32 | 32 | 37 | 45 | 56 | 62 | 64 | 61 | 84 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 227 | 238 | 386 | 605 | 718 | 536 | 458 | 493 | 355 | 265 |
| Debt incl. finance leases | 575 | 575 | 574 | 574 | 574 | 1,982 | 1,613 | 1,366 | 1,368 | 1,370 |
| Total assets | 1,413 | 1,419 | 1,560 | 2,083 | 2,225 | 4,014 | 3,963 | 4,055 | 4,304 | 4,140 |
| Total liabilities | 854 | 894 | 888 | 1,187 | 1,209 | 2,683 | 2,343 | 2,143 | 2,118 | 2,138 |
| Shareholders' equity | 560 | 526 | 672 | 896 | 1,016 | 1,331 | 1,620 | 1,912 | 2,186 | 2,002 |
| Margins and ratios | ||||||||||
| Gross margin | 53.6% | 51.2% | 53.8% | 53.5% | 50.6% | 52.8% | 53.3% | 54.1% | 52.7% | 50.6% |
| Operating margin | 28.8% | 27.1% | 30.5% | 29.4% | 29.8% | 25.8% | 30.2% | 31.8% | 32.2% | 28.3% |
| Net margin | 21.1% | 19.8% | 24.6% | 25.0% | 25.1% | 21.5% | 22.4% | 24.4% | 25.7% | 21.5% |
| Free cash flow margin | 23.2% | 26.1% | 25.6% | 28.7% | 31.0% | 26.4% | 28.0% | 27.9% | 26.6% | 28.6% |
| Return on capital | 35.9% | 31.4% | 42.5% | 44.5% | 46.6% | 23.3% | 18.2% | 20.8% | 20.7% | 18.2% |
| Return on equity | 48.0% | 49.2% | 58.9% | 47.5% | 41.8% | 33.8% | 31.7% | 30.4% | 29.1% | 25.5% |
| Return on assets | 21.2% | 18.9% | 23.7% | 20.5% | 18.6% | 12.7% | 11.7% | 13.4% | 14.3% | 12.6% |
| Net debt to EBITDA | 0.9x | 0.8x | 0.4x | −0.1x | −0.3x | 2.6x | 1.6x | 1.1x | 1.1x | 1.2x |